- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
A PCT pharmacist alleged a Teva-supported supplement about switching to CFC-free beclometasone inhalers was disguised promotion for Qvar.…
A health professional received an unsolicited email about Gilead’s UK and Ireland Fellowship Programme and queried how his…
A psychiatrist complained that a Janssen-Cilag presentation implied Risperdal Consta had neuroprotective effects. The PMCPA found the material…
Cephalon arranged delivery of 30 boxes of Schedule 2 Effentora as “titration stock” that bypassed hospital pharmacy controls.…
A ‘Getting started’ Imbruvica leaflet used the strapline ‘Destination survival’. The Panel said HCPs would read this as…
Merz challenged Allergan’s National Stroke Forum panel claiming “No set dose ratio…”. Panel found the claim reflected SPCs…
PMCPA case AUTH/3072/9/18 (Director v Servier) concerned clinical trial disclosure but was ruled outwith the scope of the…
MSD challenged a Victoza detail aid using a “triple composite endpoint” shown in prominent red boxes. PMCPA ruled…
Allergan was ruled in breach after a meeting presentation and representative conduct implied Vistabel/Botox was more potent than…
ViiV admitted a February 2015 journal issue carried a 2-page Triumeq ad plus a belly band wrap, exceeding…
One real case. One key lesson. Every week — free.